Condition
Intracranial Pathology
Total Trials
5
Recruiting
0
Active
0
Completed
1
Success Rate
25.0%-62% vs avg
Key Insights
Highlights
Success Rate
25% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
60.0%
3 terminated out of 5 trials
Success Rate
25.0%
-61.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
300%
3 of 1 completed with results
Key Signals
3 with results25% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 1 (2)
Trial Status
Terminated3
Completed1
Withdrawn1
Trial Success Rate
25.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03212976Not ApplicableTerminatedPrimary
Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure
NCT03328143Phase 1CompletedPrimary
Feasibility of Aromatherapy in an Awake Craniotomy Environment
NCT04946435Phase 1WithdrawnPrimary
Topical Antibiotic Prophylaxis for Nasal Packing Post-ESBS
NCT02388880Not ApplicableTerminated
Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion (4hour)
NCT01824576Not ApplicableTerminated
Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion
Showing all 5 trials